Incidence of febrile neutropenia (FN) with pegfilgrastim (PF) on day of chemotherapy (D1) versus 24–72 hrs later (D2) No significant financial relationships to disclose. This is an ASCO Meeting ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback